Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
BMC Medical Informatics and Decision Making|February 18, 2025
A series of natural language processing for predicting tumor response evaluation and survival curve from electronic health recordsToshiki Takeuchi, Hidehito Horinouchi, Ken Takasawa, et al.
Thoracic Cancer|December 12, 2018
Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)Yusuke Okuma, Kei Morikawa, Hisashi Tanaka, et al.
Anticancer Research|January 25, 2023
Real-world Data on the Incidence of Coronavirus Disease (COVID-19) in Patients With Advanced Thoracic Cancer During the Early Phase of the Pandemic in JapanAkito Fukuda, Tatsuya Yoshida, Shigehiro Yagishita, et al.
The Lancet. Oncology|June 6, 2020
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trialJun Sato, Miyako Satouchi, Shoichi Itoh, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2024
Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expressionJun Miyakoshi, Tatsuya Yoshida, Jumpei Kashima, et al.
BMC Cancer|October 21, 2015
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014Yusuke Takagi, Yukio Hosomi, Fumihiro Oshita, et al.
Respiratory Investigation|September 17, 2025
Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendationsMeinoshin Okumura, Kiminori Fujimoto, Nobuharu Hanaoka, et al.
Cancer Medicine|August 20, 2020
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinomaYusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsFyza Y Shaikh, James R White, Joell J Gills, et al.
European Journal of Clinical Pharmacology|January 18, 2022
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitantHideyuki Hibino, Naomi Sakiyama, Yoshinori Makino, et al.
Pageof 20